Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 11,325,860 | 11,633,070 | 8,683,947 | 11,797,590 | 11,657,940 |
| Marketable Securities | 5,857,450 | 5,500,646 | 8,148,117 | 5,183,721 | 4,276,525 |
| Receivables | 273,002 | 706,102 | 1,105,151 | 906,599 | 1,632,418 |
| Inventories | 116,968 | 121,488 | 125,246 | 263,821 | 261,891 |
| Other current assets | 212,890 | 217,114 | 205,799 | 352,779 | 253,936 |
| TOTAL | $17,786,170 | $18,178,420 | $18,268,260 | $18,504,510 | $18,082,710 |
| Non-Current Assets | |||||
| PPE Net | 1,204,673 | 1,302,304 | 1,222,930 | 1,215,305 | 1,155,407 |
| Investments And Advances | 2,332,492 | 2,668,395 | 2,889,822 | 2,894,196 | 2,843,449 |
| Intangibles | 2,086,930 | 2,244,008 | 2,233,270 | 2,042,653 | 2,101,368 |
| Other Non-Current Assets | 242,075 | 272,001 | 263,617 | 288,953 | 380,065 |
| TOTAL | $5,866,170 | $6,486,708 | $6,609,639 | $6,441,106 | $6,480,289 |
| Total Assets | $23,652,340 | $24,665,130 | $24,877,900 | $24,945,610 | $24,563,000 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 66,506 | 66,362 | 59,059 | 62,419 | 59,485 |
| Accounts payable and accrued liabilities | 751,918 | 548,684 | 605,186 | 467,326 | 572,368 |
| Other current liabilities | 1,423,261 | 1,406,119 | 1,685,333 | 2,060,771 | 1,464,976 |
| TOTAL | $2,266,335 | $2,065,756 | $2,423,798 | $2,597,880 | $2,101,028 |
| Non-Current Liabilities | |||||
| Long Term Debt | 301,023 | 288,035 | 243,477 | 224,429 | 246,565 |
| Other Non-Current Liabilities | 399,620 | 365,516 | 364,990 | 496,899 | 1,176,067 |
| TOTAL | $739,361 | $715,466 | $703,844 | $749,616 | $1,454,986 |
| Total Liabilities | $3,005,696 | $2,781,221 | $3,127,642 | $3,347,496 | $3,556,014 |
| Shareholders' Equity | |||||
| Common Shares | 301,139 | 303,134 | 293,033 | 290,589 | 282,211 |
| Retained earnings | N/A | 20,400,070 | N/A | 21,352,180 | N/A |
| Other shareholders' equity | -1,676,689 | -1,701,085 | -1,654,153 | -1,734,295 | -1,679,041 |
| TOTAL | $20,646,640 | $21,883,900 | $21,750,260 | $21,598,120 | $21,006,990 |
| Total Liabilities And Equity | $23,652,336 | $24,665,121 | $24,877,902 | $24,945,616 | $24,563,004 |